Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
2.680
-0.010 (-0.37%)
Apr 1, 2026, 4:00 PM EDT - Market closed
Cabaletta Bio Market Cap
Cabaletta Bio has a market cap or net worth of $298.34 million as of April 1, 2026. Its market cap has increased by 265.51% in one year.
Market Cap
298.34M
Enterprise Value
191.84M
1-Year Change
265.51%
Ranking
Category
Stock Price
$2.68
Market Cap Chart
Since October 25, 2019, Cabaletta Bio's market cap has increased from $235.53M to $298.34M, an increase of 26.67%. That is a compound annual growth rate of 3.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 298.34M | 41.52% |
| Dec 31, 2025 | 210.82M | 90.01% |
| Dec 31, 2024 | 110.95M | -88.59% |
| Dec 29, 2023 | 972.68M | 260.85% |
| Dec 30, 2022 | 269.55M | 151.03% |
| Dec 31, 2021 | 107.38M | -64.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Palisade Bio | 295.27M |
| PepGen | 292.36M |
| Ovid Therapeutics | 278.26M |
| Inhibikase Therapeutics | 269.27M |
| SAB Biotherapeutics | 265.64M |
| Protara Therapeutics | 262.31M |
| Anavex Life Sciences | 261.33M |
| LENZ Therapeutics | 259.93M |